Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-25-023992
Filing Date
2025-11-18
Accepted
2025-11-18 08:15:10
Documents
3
Period of Report
2025-11-18

Document Format Files

Seq Description Document Type Size
1 6-K form6-k.htm 6-K 18013
2 EX-99.1 ex99-1.htm EX-99.1 14602
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3566
  Complete submission text file 0001493152-25-023992.txt   38687
Mailing Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003
Business Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003 972 54-255-3956
Nasus Pharma Ltd (Filer) CIK: 0002029039 (see all company filings)

EIN.: 516022712 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42796 | Film No.: 251492894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)